Welcome to LookChem.com Sign In|Join Free

CAS

  • or

119197-34-1

Post Buying Request

119197-34-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

119197-34-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 119197-34-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,1,9 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 119197-34:
(8*1)+(7*1)+(6*9)+(5*1)+(4*9)+(3*7)+(2*3)+(1*4)=141
141 % 10 = 1
So 119197-34-1 is a valid CAS Registry Number.

119197-34-1Relevant articles and documents

A generalized exo-anomeric effect. Substituent and solvent effects on the conformational equilibria of 2-(Arylseleno)cyclohexanones

McLeod, Ronald G.,Johnston, Blair D.,Pinto, B. Mario

, p. 307 - 316 (2000)

The effects of substitution and solvent on the conformational equilibria of 2-[(4-R-substituted-phenyl)seleno]cyclohexanones are described. The conformational equilibria were determined by comparison of the linewidths of the H-2 resonances in the 1H NMR spectra of the conformationally averaged systems with those of the anancomeric (highly biased) 4-isopropyl-2-substituted cyclohexanones. The substituent (R = NMe2, OMe, Me, H, F, Cl, CF3, NO2) and solvent ((CD3)2CO, CD3CN, CD2Cl2, CDCl3) effects are discussed in terms of electrostatic effects and the possible stabilizing orbital interactions. The values of Keq (axial-equatorial) increase as the substituent becomes more electron withdrawing, in agreement with the dominance of nSe→π*C=O or σC-Se→π*C=O orbital interactions in the axial conformers. The increase in the proportion of the equatorial isomers in more polar solvents for a given substituent suggests a damping of the dipolar interactions in the equatorial isomers. However, the proportion of the equatorial isomers in a given solvent increases as the substituent becomes more electron withdrawing, indicating that electrostatic interactions do not dominate in controlling the conformational equilibria. Analysis of the equilibrium data by means of a dual substituent parameter approach indicates the best correlation with σI and σ+R substituent constants in CD2Cl2, and with σI and σOR substituent constants in CD3CN, with similar sensitivities to the resonance and polar effects. The correlations are interpreted in terms of accommodation of effective positive charge on the selenium atom in the axial isomers in CD2Cl2, and a lesser sensitivity to the buildup of positive charge in the more polar solvent CD3CN. Comparison of the IR vCO-stretching frequencies for the axial and equatorial ArSe-substituted anancomeric systems (R = NO2, NMe2) indicates a higher stretching frequency for the NO2-substituted isomers. In the case of the NMe2-substituted compounds, vCO appears at a higher frequency in the equatorial isomer, whereas in the case of the NO2-substituted compounds, vCO is less sensitive to the axial or equatorial orientation of the substituent. The results are consistent with the operation of nSe→π*C=O or σC-Se→π*C=O orbital interactions in the axial isomers. The JC2-H2 values in the axially-substituted anancomeric isomers are of greater magnitude than those in the equatorially-substituted isomers, which is also consistent with the operation of the orbital interactions described above. There is, however, no marked substituent effect on the JC2-H2 values within the series of axial or equatorial isomers. We argue that this does not support the dominance of σC-Se→π*C=O orbital interactions. Examination of crystal structures reported in the literature for related compounds indicates a particular gauche orientation about the C2-Se bond, which lends further support to the operation of an nSe→π*C=O orbital interaction. We suggest that the latter interaction is a manifestation of a generalized exo-anomeric effect.

Prostaglandin endoperoxide H synthase biosynthesis inhibitors

-

, (2008/06/13)

The present invention describes pyridazinone compounds of formula I which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important “housekeeping” enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectivity of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 119197-34-1